When inflammation in the body goes unchecked, it can cause fibrosis, or tissue scarring that may lead to organ dysfunction or ...

A new report from the American Cancer Association predicts lung cancer will cause more deaths than any other in 2026.

Boehringer Ingelheim begins phase IIa trial of BI 765423, a novel monoclonal antibody targeting IL-11, in patients with idiopathic pulmonary fibrosis: Ingelheim, Germany Thursday, ...

A FORMER Fine Gael election candidate has died after a health battle with tributes pouring in for the well-respected man.

What Is Jascayd, and Why Does It Matter? Jascayd (nerandomilast) is now approved for treating adults with progressive pulmonary fibrosis (PPF) that causes gradual and permanent scarring in the lungs, ...

Not intended for US and UK audiencesBI 765423 has been developed to target IL-11, a key driver of fibrosisNew study will investigate potential of ...

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...

Reality star Katie Price brought tears of joy to her mother, Amy - who is battling a terminal lung disease called IPF - as she gave her a thoughtful present for Christmas ...

A 45-year-old woman presents with long-standing exertional dyspnea, wheezing, and intermittent dry cough, which has been ongoing for over the past 10 years.

There is still a debate about very high-level endurance exercise. While most recreational runners show no lasting harm, some ...

Not intended for US and UK audiences BI 765423 has been developed to target IL-11, a key driver of fibrosis New study will investigate potential of BI 765423 to improve lung function for patients ...

Interim data from Phase 1 with single and multiple ascending doses show no safety signals and a generally favorable tolerability profile of ...